Genetic association study of UCMA/GRP and OPTN genes (PDB6 locus) with Paget's disease of bone

Bone

Volumn 51, Issue 4, 2012, Pages 720-728

  Michou, Laëtitia ^a   Conceição, Natércia ^b   Morissette, Jean ^a   Gagnon, Edith ^a   Miltenberger Miltenyi, Gabriel ^c   Siris, Ethel S ^d   Brown, Jacques P ^a   Cancela, M Leonor ^b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY OF ALGARVE   (Portugal)

^c INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^d NewYork Presbyterian Hospital   (United States)

Author keywords

OPTN gene; Paget's disease of bone; Sox2 binding site; Transcription regulation; UCMA GRP gene

Indexed keywords

ADULT; ALLELE; ARTICLE; BINDING SITE; CONTROLLED STUDY; EMBRYO; FEMALE; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; MUTATOR GENE; NUCLEOTIDE SEQUENCE; OPTINEURIN GENE; PAGET BONE DISEASE; PROMOTER REGION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSACTIVATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; UPPER ZONE OF GROWTH PLATE AND CARTILAGE MATRIX ASSOCIATED GLA RICH PROTEIN GENE;

CASE-CONTROL STUDIES; HAPLOTYPES; HEK293 CELLS; HUMANS; OSTEITIS DEFORMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTOR TFIIIA;

EID: 84865636771     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.06.028     Document Type: Article

References (34)

1. van Staa T.P., Selby P., Leufkens H.G., Lyles K., Sprafka J.M., Cooper C. Incidence and natural history of Paget's disease of bone in England and Wales. J Bone Miner Res 2002, 17:465-471.
2. Rousiere M., Michou L., Cornelis F., Orcel P. Paget's disease of bone. Best Pract Res Clin Rheumatol 2003, 17:1019-1041.
3. Morissette J., Laurin N., Brown J.P. Sequestosome 1: mutation frequencies, haplotypes, and phenotypes in familial Paget's disease of bone. J Bone Miner Res 2006, 21(Suppl. 2):P38-P44.
4. Laurin N., Brown J.P., Lemainque A., Duchesne A., Huot D., Lacourciere Y., et al. Paget disease of bone: mapping of two loci at 5q35-qter and 5q31. Am J Hum Genet 2001, 69:528-543.
5. Laurin N., Brown J.P., Morissette J., Raymond V. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet 2002, 70:1582-1588.
6. Hocking L.J., Herbert C.A., Nicholls R.K., Williams F., Bennett S.T., Cundy T., et al. Genomewide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35. Am J Hum Genet 2001, 69:1055-1061.
7. Lucas G.J., Riches P.L., Hocking L.J., Cundy T., Nicholson G.C., Walsh J.P., et al. Identification of a major locus for Paget's disease on chromosome 10p13 in families of British descent. J Bone Miner Res 2008, 23:58-63.
8. Albagha O.M., Visconti M.R., Alonso N., Langston A.L., Cundy T., Dargie R., et al. Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone. Nat Genet 2010, 42:520-524.
9. Rezaie T., Child A., Hitchings R., Brice G., Miller L., Coca-Prados M., et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002, 295:1077-1079.
10. Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010, 465:223-226.
11. Albagha O.M., Wani S.E., Visconti M.R., Alonso N., Goodman K., Brandi M.L., et al. Genome-wide association identifies three new susceptibility loci for Paget's disease of bone. Nat Genet 2011, 43:685-689.
12. Chung P.Y., Beyens G., Boonen S., Papapoulos S., Geusens P., Karperien M., et al. The majority of the genetic risk for Paget's disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes. Hum Genet 2010, 128:615-626.
13. Viegas C.S., Simes D.C., Laize V., Williamson M.K., Price P.A., Cancela M.L. Gla-rich protein (GRP), a new vitamin K-dependent protein identified from sturgeon cartilage and highly conserved in vertebrates. J Biol Chem 2008, 283:36655-36664.
14. Surmann-Schmitt C., Dietz U., Kireva T., Adam N., Park J., Tagariello A., et al. Ucma, a novel secreted cartilage-specific protein with implications in osteogenesis. J Biol Chem 2008, 283:7082-7093.
15. Tagariello A., Luther J., Streiter M., Didt-Koziel L., Wuelling M., Surmann-Schmitt C., et al. Ucma-a novel secreted factor represents a highly specific marker for distal chondrocytes. Matrix Biol 2008, 27:3-11.
16. Viegas C.S., Cavaco S., Neves P.L., Ferreira A., Joao A., Williamson M.K., et al. Gla-rich protein is a novel vitamin K-dependent protein present in serum that accumulates at sites of pathological calcifications. Am J Pathol 2009, 175:2288-2298.
17. Le Jeune M., Tomavo N., Tian T.V., Flourens A., Marchand N., Camuzeaux B., et al. Identification of four alternatively spliced transcripts of the Ucma/GRP gene, encoding a new Gla-containing protein. Exp Cell Res 2010, 316:203-215.
18. Pankiv S., Lamark T., Bruun J.A., Overvatn A., Bjorkoy G., Johansen T. Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies. J Biol Chem 2010, 285:5941-5953.
19. Goode A., Layfield R. Recent advances in understanding the molecular basis of Paget disease of bone. J Clin Pathol 2009, 63:199-203.
20. Cancela M.L., Conceiçao N., Laizé V. Gla rich protein, a new player in tissue calcification?. Adv. Nutr. 2012, 3:174-181.
21. Michou L., Morissette J., Gagnon E.R., Marquis A., Dellabadia M., Brown J.P., et al. Novel SQSTM1 mutations in patients with Paget's disease of bone in an unrelated multiethnic American population. Bone 2011, 48:456-460.
22. Staden R. The Staden sequence analysis package. Mol Biotechnol 1996, 5:233-241.
23. Desmet F.O., Hamroun D., Lalande M., Collod-Beroud G., Claustres M., Beroud C. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 2009, 37:e67.
24. Luu-The V., Paquet N., Calvo E., Cumps J. Improved real-time RT-PCR method for high-throughput measurements using second derivative calculation and double correction. Biotechniques 2005, 38:287-293.
25. Rath M.F., Bailey M.J., Kim J.S., Coon S.L., Klein D.C., Moller M. Developmental and daily expression of the Pax4 and Pax6 homeobox genes in the rat retina: localization of Pax4 in photoreceptor cells. J Neurochem 2009, 108:285-294.
26. Singh D.P., Bhargavan B., Chhunchha B., Kubo E., Kumar A., Fatma N. Transcriptional protein Sp1 regulates LEDGF transcription by directly interacting with its cis-elements in GC-rich region of TATA-less gene promoter. PLoS One 2012, 7:e37012.
27. Fahmi H., Martel-Pelletier J., Pelletier J.P., Kapoor M. Peroxisome proliferator-activated receptor gamma in osteoarthritis. Mod Rheumatol 2011, 21:1-9.
28. Chen K., Aenlle K.K., Curtis K.M., Roos B.A., Howard G.A. Hepatocyte growth factor (HGF) and 1,25-dihydroxyvitamin D together stimulate human bone marrow-derived stem cells toward the osteogenic phenotype by HGF-induced up-regulation of VDR. Bone 2012, 51:69-77.
29. Avilion A.A., Nicolis S.K., Pevny L.H., Perez L., Vivian N., Lovell-Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 2003, 17:126-140.
30. Lefebvre V., Dumitriu B., Penzo-Mendez A., Han Y., Pallavi B. Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors. Int J Biochem Cell Biol 2007, 39:2195-2214.
31. Basu-Roy U., Ambrosetti D., Favaro R., Nicolis S.K., Mansukhani A., Basilico C. The transcription factor Sox2 is required for osteoblast self-renewal. Cell Death Differ 2010, 17:1345-1353.
32. Tong C.K., Vellasamy S., Tan B.C., Abdullah M., Vidyadaran S., Seow H.F., et al. Generation of mesenchymal stem cell from human umbilical cord tissue using a combination enzymatic and mechanical disassociation method. Cell Biol Int 2011, 35:221-226.
33. Layfield R., Shaw B. Ubiquitin-mediated signalling and Paget's disease of bone. BMC Biochem 2007, 8(Suppl. 1):S5.
34. Shankar S., Hosking D.J. Biochemical assessment of Paget's disease of bone. J Bone Miner Res 2006, 21(Suppl. 2):P22-P27.